Skip to main content
Glama

Openverse

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already mark it read-only, open-world, idempotent, and non-destructive. The description adds substantial behavioral context: ambiguous matches return figi_candidates instead of asserting, unresolved identifiers are explicit, enrichment degrades gracefully, and identifiers are source-labelled.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long, but the length is justified by two entity types, multiple identifier sources, and edge-case caveats. The most actionable guidance is front-loaded, though some later detail is dense and could be trimmed without losing essential behavior.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description carries the full burden of explaining results, and it does so thoroughly: ambiguous matches, unresolved fields, source labels, graceful degradation, and the return of RxCUI/ingredient/brand for drugs. An agent has enough context to call it correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Though schema coverage is 100%, the description adds decisive meaning beyond the schema: company value accepts ticker, CIK, ISIN, or name; drug value accepts brand or generic name; and it warns to pass the bond issuer exactly as printed rather than the full noun phrase. This materially reduces misuse risk.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete query examples and states the core action: resolving a user-spoken NAME to canonical/official identifiers. It clearly positions the tool as the input provider for other tools, which distinguishes it from profile/compare siblings.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It gives an explicit trigger: 'Use FIRST whenever you have a name but need an ID.' It also defines supported entity types and input forms. However, it does not name alternative tools or state when not to use it, leaving some substitution logic implicit.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Openverse toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.9/5.0
Disambiguation2/5

Several tools occupy the same functional space: ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded, deep_research, and validate_claim all answer factual questions from Pipeworx data, and ask_pipeworx_beta is explicitly identical to ask_pipeworx right now. The prediction-market tools also heavily overlap in purpose, as do ai_visibility_check and scan_competitor_ai_presence. Only the Openverse media tools and memory/subscription tools are cleanly distinguishable.

Naming Consistency3/5

All names are lowercase snake_case, but the naming conventions are mixed: verb_noun tools like search_images and resolve_entity coexist with bare verbs like remember, recall, forget, and subscribe, plus noun compounds like entity_profile, polymarket_edges, and bet_research. Subfamilies such as polymarket_* and the audio/image tools are internally consistent, but there is no single predictable pattern across the full set.

Tool Count2/5

37 tools exceeds the 25+ threshold and feels inflated for the surface, especially since several could be consolidated: there are three ask_pipeworx variants and five overlapping prediction-market tools. The Openverse-specific core is only 6 tools, with 31 mostly unrelated Pipeworx and utility tools attached, making the server feel like a grab-bag rather than a purpose-built Openverse integration.

Completeness4/5

Each embedded subdomain covers its main lifecycle well: Openverse has search/get/related for images and audio, memory has remember/recall/forget, subscriptions have subscribe/list/unsubscribe/recent_alerts, and research has ask, grounded, deep_research, entity_profile, compare_entities, resolve_entity, and validate_claim. Minor gaps exist—notably no Openverse video/collection tooling and no explicit memory update—but agents can work around them without hitting dead ends.

Resources